NO. |
Intermediates |
SPECIFICATION |
CAS |
USAGE |
1 |
2,7-dihydroxy-9H-fluoren-9-one |
≥99% |
42523-29-5 |
|
2 |
L-Alanyl-L-Glutamine |
|
121574-43-4 |
|
3 |
N-methyl-2-pyrrolidone |
|
872-50-4 |
|
4 |
N-succinimide |
|
123-56-8 |
|
5 |
1,3-Propandiol |
|
162359-55-9 |
|
6 |
Thiophene-2-ethanol |
|
5402-55-1 |
|
7 |
Dimethyldioxolone;4,5-Dimethyl-1,3-dioxol-2-one |
≥99% |
37830-90-3 |
|
8 |
1-(3-Trifluoromethylphenyl)piperazine monohydrochloride |
≥99% |
16015-69-3 |
|
9 |
1-(4-Methoxyphenyl)piperazine dihydrochloride |
≥99% |
38869-47-5 |
|
10 |
4-Fluoro-a-[2-methyl-1-oxopropyl]-γ-oxo-N,β-diphenylbenzene butaneamide |
|
125971-96-2 |
Atorvastatin Calcium |
11 |
(4R,Cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
|
125971-94-0 |
Atorvastatin Calcium |
12 |
Methyl4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino) pyrimidine-5-Carboxylate r
|
≥98.5% |
289042-11-1 |
Rosuvastatin |
13 |
Methyl(+)-(3R,5S)-7-[4-(4-Fluorophenyl)-6-Isopropyl-2-(N-Methyl-N-Methanesul
fonylamino)pyrimidin-5-yl]-3,5-Dihydroxy-6(E)-Heptenoate |
≥98.5% |
147118-40-9 |
Rosuvastatin |
14 |
Ethyl2-(3-cyano-4-isobutoxyphenyl)- 4-methyl-5-thiazolecarboxylate |
|
160844-75-7 |
Febuxostat |
15 |
ethyl 2-(4-hydroxy-3-nitrophenyl)-4-methyl-1,3-thiazole-5-carboxylate |
|
161797-99-5 |
Febuxostat |
16 |
4-hydroxy-3-nitrobenzenecarbothioamide |
|
25984-63-8 |
Febuxostat |
17 |
3-BROMO-4-ISOBUTOXYBENZOTHIOAMIDE |
|
208665-96-7 |
Febuxostat |
18 |
Diethyl (tosyloxy)methylphosphonate (DESMP) |
|
31618-90-3 |
Tenofovir disoproxil fumerate |
19 |
Tenofovir (R-PMPA) |
|
147127-20-6 |
Tenofovir disoproxil fumerate |
20 |
(s)-2-Aminobutyramide Hydrochloride |
|
7682-20-4 |
Levetiracetam |
21 |
4-N,N-dimethylaminobutanal diethyl acetal |
|
1116-77-4 |
Rizatriptan benzoate |
26 |
4-N,N-dimethylaminobutanal dimethyl acetal |
|
29882-07-3 |
Rizatriptan benzoate |
27 |
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride |
|
106261-49-8 |
Imatinib |
28 |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine |
|
152460-10-1 |
Imatinib |
30 |
3-(N-methylpentylamino)propionic acid HCL |
|
625120-81-2 |
Ibandronate |
31 |
2-Hydroxi-4,5,6,7-Tetrahydrothieno[3,2-C]Piperidine Hydrochloride |
|
115473-15-9 |
PRASUGREL |
32 |
Cyclopropyl 2-fluorobenzyl ketone |
|
150322-73-9 |
PRASUGREL |
33 |
3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester |
|
212322-56-0 |
Dabigatran |
34 |
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester |
|
211915-84-3 |
Dabigatran |
35 |
N-[[2-[[[4-(aminoiminomethyl)phenyl] amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl] -N-2-pyridinyl-beta-Alanine ethyl ester |
|
429658-95-7 |
Dabigatran |
36 |
4'-Methyl-2-cyanobiphenyl |
|
114772-53-1 |
Sartans |
37 |
4-Bromomethyl-2-cyanobiphenyl |
|
114772-54-2 |
Sartans |
38 |
N-(Triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)tetrazole (BBTT) |
|
124750-51-2 |
Sartans |
39 |
6-Ethynyl-4,4-dimethylthiochroman |
|
118292-06-1 |
Tazarotene |
40 |
4-(3-fluorobenzyloxy)-benzaldehyde |
|
66742-57-2 |
Safinamide |
